Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Apr 10, 2007 by Edgar Snyder

Group Wants Celebrex Advertisement to Stop


Public Citizen, a consumer advocacy group, has gone to the Food and Drug Administration (FDA) to stop Pfizer from airing their new Celebrex television ad. The ad began last week after the FDA put a stop to them in 2004 over concerns the drug raised the risks of heart attacks and strokes.

Public Citizen claims the new Celebrex ad is misleading and plays down the cardiovascular and gastrointestinal risks of the drug. According to the FDA, Pfizer submitted the ad for review before putting it on the air. The FDA has told the consumer advocacy group that they will look into their claims and take the appropriate action.

Celebrex is the only Cox-2 inhibitor still on the U.S. market. Bextra and Vioxx were removed for the cardiovascular problems associated with them.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio and West Virginia, and we associate with experienced attorneys in other states. In addition, all drug-related litigation may involve co-counsel.

Source: “FDA Is Asked to Halt Celebrex Ad.” By Jennifer Corbett Dooren. The Wall Street Journal. April 10, 2007.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers